Background: Fibromyalgia syndrome (FMS) is a complex condition with poorly understood pathophysiology, characterized by widespread pain and an increasing recognition of its associations with genitourinary symptoms. The objective of this study was to characterize the prevalence, phenotype, and common comorbidities of lower urinary tract symptoms (LUTS) in women with FMS. Methods: A retrospective observational study was conducted using electronic medical records of 440 women diagnosed with FMS at a single institution between 1 January 2018, and 1 January 2024. Study subjects were evaluated for diagnoses associated with LUTS, including interstitial cystitis (IC), overactive bladder (OAB), and stress urinary incontinence (SUI), alongside comorbidities such as irritable bowel syndrome (IBS), generalized anxiety disorder (GAD), and major depressive disorder (MDD). Multivariate analyses were performed to assess predictors of conditions associated with LUTS. Results: LUTS were identified in 37.0% of FM patients. GAD and IBS were significantly associated with conditions associated with LUTS (OR = 4.62; OR = 8.53, p < 0.001). SUI was present in 17.05% of patients, falling between survey-based and confirmed prevalence rates in the general population. IC was diagnosed in 2.95% of FMS patients. OAB was observed in 6.8% of patients and associated with GAD (OR = 5.98, p < 0.001). Conclusions: This study highlights a substantial burden of diagnoses associated with LUTS in patients with FMS. There is relatively high prevalence of SUI and IC in this dataset. IBS and GAD were commonly found to co-occur with one or more LUTS-associated condition. Future prospective studies are needed to investigate a multimodal approach to the treatment of LUTS in these patients.
Research output has become an increasingly important criterion for competitive fellowship applications. While prior studies have quantified this trend in other specialties, the same has not been done for cardiology fellowships. This retrospective cohort study included cardiology fellows from two cohorts, ten years apart, at 10 of the top 25-ranked U.S. cardiology programs selected from Doximity’s reputation rankings. PubMed was utilized to quantify research output prior to fellowship entry. Primary outcomes were total publications, first-author publications, and cardiology-related (“in-specialty”) publications. Among 155 fellows (72 in 2017; 83 in 2027), the mean total number of publications increased from 2.67±3.22 in 2017 to 7.18±9.34 in 2027. First-authorships increased from 1.35±2.25 to 2.54±3.30, and in-specialty publications rose from 1.79±2.90 to 4.81±8.58. Logistic regression showed that the 2027 cohort was significantly more likely to have ≥1 publication (OR 2.3 [95% CI, 1.14–3.50]; p< 0.001). Degree type, institutional transitions, and geographic mobility were not significant predictors. Cardiology fellowship applicants in 2027 had markedly higher research output compared to the class of 2017, indicating a growing emphasis on scholarly productivity in the selection processes. These findings raise questions about equitable access to research opportunities and the potential emergence of barriers to scholarly output among aspiring cardiologists.